Tag: News Roundup

Pharmacology News Digest, August 28th, 2018

 

 

This week in clinical pharmacology news: ​​ FDA approves new drugs for​​ neurotrophic keratitis, Dravet syndrome, and​​ hereditary angioedema. Glutamine shows promise in​​ post-infectious​​ IBS, any level of alcohol intake increases all-cause mortality, and aspirin is not effective in​​ primary prevention of cardiovascular disease.

-​​ August 27th, 2018

 


Continue reading “Pharmacology News Digest, August 28th, 2018”

Advertisements

Pharmacology News Digest, July 15th

Continue reading “Pharmacology News Digest, July 15th”

Pharmacology News Round-Up: June 28th, 2018

Continue reading “Pharmacology News Round-Up: June 28th, 2018”

Pharmacology News Round-Up: June 21st, 2018

This week’s clinical pharmacology highlights include advances in cancer therapy, long-term followup of the landmark PROACT trial comparing anticoagulation strategies after aortic replacement, and the finding that hydrocortisone may not reduce mortality in septic shock.

Continue reading “Pharmacology News Round-Up: June 21st, 2018”

Weekly Pharmacology News Round-Up: June 8th – June 14th 2018

This week’s clinical pharmacology highlights include a new treatment for river blindness, further success for JAK inhibitors in inflammatory diseases, and the finding that more patients are taking medications associated with depressive symptoms.

Continue reading “Weekly Pharmacology News Round-Up: June 8th – June 14th 2018”